quinazolines has been researched along with Cancer of Duodenum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, N; Enomoto, N; Fujisawa, T; Furuhashi, K; Hozumi, H; Inui, N; Iwaizumi, M; Karayama, M; Kono, M; Kusama, Y; Nakamura, Y; Suda, T; Suzuki, Y | 1 |
Andress, L; Bridges, AJ; Burgart, LJ; Fry, DW; Gendler, SJ; Karnes, WE; Nelson, JM; Ritland, SR | 1 |
2 other study(ies) available for quinazolines and Cancer of Duodenum
Article | Year |
---|---|
Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Carcinoma, Non-Small-Cell Lung; Duodenal Neoplasms; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mutation; Pyrimidines; Quinazolines; Treatment Outcome | 2017 |
Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injury.
Topics: Acrylamides; Adenoma; Animals; Anticarcinogenic Agents; Dose-Response Relationship, Drug; Duodenal Neoplasms; Enzyme Inhibitors; ErbB Receptors; Female; Genes, APC; Genetic Predisposition to Disease; Growth Substances; Male; Mice; Mice, Inbred C57BL; Mucins; Muscle Proteins; Neuropeptides; Peptides; Phosphorylation; Protein Biosynthesis; Quinazolines; Signal Transduction; Trefoil Factor-2; Trefoil Factor-3 | 2000 |